Aug 2026· International Journal of Public Health and Medical Research· 0 citations· 54 references
TL;DR
Evidence related to brain network reorganization and synaptic plasticity-associated regulation in ECT for depression is summarized and how findings across levels may be integrated to inform future mechanistic research and treatment-response prediction is discussed.
Abstract
Electroconvulsive therapy (ECT) is an important treatment for severe, treatment-resistant, or high-risk depression, yet the relationship between its antidepressant effects, brain network changes, and cellular and molecular processes remains incompletely understood. Recent advances in multimodal magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), molecular biology, and animal electroconvulsive stimulation models have provided multilevel evidence for understanding the neurobiological mechanisms of ECT in depression. Current studies suggest that ECT is accompanied by changes in functional connectivity within large-scale brain networks, including the default mode network (DMN), the frontoparietal control network (FPCN), and prefrontal-limbic circuits. In parallel, processes involving neurotransmission, brain metabolism, neurotrophic factors, inflammatory responses, and synaptic plasticity may provide biological clues for interpreting these network-level changes. This review summarizes evidence related to brain network reorganization and synaptic plasticity-associated regulation in ECT for depression, and discusses how findings across levels may be integrated to inform future mechanistic research and treatment-response prediction.
Abstract Background Electroconvulsive therapy (ECT) is among the most effective treatments for severe and treatment-resistant depression. Despite more than 90 years of clinical use, its underlying neurobiological mechanisms remain incompletely understood. One prominent hypothesis suggests that ECT induces neuroplastic...
P. Baldinger-Melich, S. Riessland, B. Spurny-Dworak et al.· International Journal of Neu...· 0 citations
The pathophysiology of depression involves multiple biological processes, including circuit dysfunction and impaired neuroplasticity, yet an integrative view linking these processes remains elusive. Here, we identify a convergent circuit for antidepressant response and plasticity modulation. We demonstrate that chemoge...
M. Veleanu, Louise Schuberth, Antje Kilias et al.· Nature Communications· 0 citations
An illustrative multilevel, reciprocal pathophysiological framework that integrates evidence across brain network (macro), neurotransmitter (meso), and molecular and systemic scales that contribute to depression vulnerability in HD is presented.
Tamrin Barta, Y. Glikmann-Johnston, P. McColgan et al.· Neuroscience and Biobehavior...· 0 citations
BACKGROUND AND PURPOSE
Electroconvulsive therapy (ECT) is efficacious for the treatment of major depressive disorder. However, its underlying mechanism of action remains debated and may involve neurogenesis, changes in axon/synaptic density or glial cells. Restriction spectrum imaging (RSI) is an MRI technique that can...
Christopher G. Filippi, Matthew Yh Leung, A. M. Uluğ et al.· AJNR. American journal of ne...· 0 citations
This review aims to provide a comprehensive framework for developing safer, more effective, and more precise interventions for cognitive impairment by integrating neurobiological mechanisms, neuropathological insights, and therapeutic innovation.
Neurostimulation of targeted brain regions has emerged as a novel therapeutic approach to induce remission in patients with various psychiatric disorders. This strategy encompasses several modalities, including transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), deep brain stimulati...
F. Bambico, A. Nicoglou, J. Relente et al.· Molecular Psychiatry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.